Aidspan publishes new issue of 'Global Fund Observer'

Oct 20 2012NewsGuard 100/100 Score

Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Thursday published Issue 199 of its "Global Fund Observer." The issue features an article on a diagnostic review of Global Fund grants in Peru; a commentary by Aidspan's David Garmaise on language used in the Global Fund's Office of the Inspector General reports; an article looking at Global Fund grants to Nigeria, which include $50 million in "new" money to purchase bed nets; as well as several other articles (10/18).

http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Posted in: Healthcare News

Tags: , , , , , ,

Comments (0)

Suggested Reading

Rutgers study sheds light on how bedaquiline fights drug-resistant tuberculosis
A promising new strategy for malaria drug development
Study finds artemisinin resistance in African children with severe malaria
Malaria crystal structure offers clues for more effective medications
New test promises to end malaria
Maternal antibodies may hinder malaria vaccine effectiveness in infants
Study finds high risk of pediatric tuberculosis in high-burden areas
TB pathogen's surprising growth mechanism challenges bacterial biology

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Artemisinin resistance detected in children with severe malaria in Uganda